Apimeds Pharmaceuticals US Files for 3.33M Share IPO at $3-$4/sh by November 8, 2024 November 8, 2024 Apimeds Pharmaceuticals US (APUS) has filed for 3,333,334 share IPO at $3-$4 per share. This post appeared first on investing.com previous post Multiple climate disasters trigger first ever Red Cross disaster insurance pay-out next post Richemont shares fall amid sluggish China demand, margin pressures